Teladoc Health (TDOC) Stock News

Teladoc Health (NYSE: TDOC) has launched enhanced AI capabilities for its Virtual Sitter solution to improve patient safety in hospitals. The new technology enables a single remote staff member to monitor up to 25% more patients, addressing the critical issue of hospital falls, which affect nearly 1 million patients annually and cost approximately $50 billion in medical expenses. The AI-enabled system uses advanced algorithms, motion detection, and pose estimation to detect potentially dangerous patient movements, allowing faster intervention. The solution runs on Teladoc's TV Pro devices using local processing for enhanced security and performance.

Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, announced its participation in the 36th Annual Piper Sandler Healthcare Conference. The event will take place in New York on Tuesday, December 3, 2024, at 12:30 p.m. ET. CEO Chuck Divita and CFO Mala Murthy will represent the company. A live audio webcast and replay of the presentation will be accessible through Teladoc's investor relations website.

Teladoc Health (NYSE:TDOC) has granted inducement awards to two new non-executive employees, effective November 1, 2024. The awards consist of restricted stock units covering 70,575 shares of common stock. The vesting schedule includes one-third of shares on the first anniversary, with the remaining shares vesting quarterly over the following two years. These awards were approved by the Compensation Committee under the 2023 Employment Inducement Incentive Award Plan, complying with NYSE Rule 303A.08.

Teladoc Health (TDOC) reported Q3 2024 financial results with revenue of $640.5 million, down 3% year-over-year. The company posted a net loss of $33.3 million, or $0.19 per share, improving from a $57.1 million loss in Q3 2023. Integrated Care segment revenue grew 2% to $383.7 million, while BetterHelp segment declined 10% to $256.8 million. Adjusted EBITDA decreased 6% to $83.3 million. International revenue showed strength with 15% growth to $104.3 million, while U.S. revenue declined 6% to $536.2 million.

Teladoc Health Inc. (NYSE: TDOC), the global leader in whole-person virtual care, has announced the release date for its third quarter 2024 financial results. The results will be disclosed on Wednesday, October 30, 2024, after the market closes. Following the release, the company will host a conference call at 4:30 p.m. E.T. to review the results.

Participants can join the conference call by dialing 1-833-470-1428 (U.S.) and using the access code # 781291. International participants can find global dial-in numbers at a provided link. A live audio webcast will be available at the Teladoc Health investor relations website. A replay of the call will be accessible via webcast shortly after completion and remain available for approximately 90 days.

Teladoc Health (NYSE:TDOC), the global leader in whole-person virtual care, has announced the issuance of inducement awards to three new non-executive employees. Effective October 1, 2024, these employees were granted awards of restricted stock units covering a total of 105,000 shares of Teladoc Health's common stock. The vesting schedule for these units is as follows:

• One-third of the underlying shares vest on the first anniversary of the grant date
• The remaining shares vest quarterly over the subsequent two years

These awards were approved by the Compensation Committee of Teladoc Health's Board of Directors and were granted under the company's 2023 Employment Inducement Incentive Award Plan, in compliance with New York Stock Exchange Rule 303A.08.

Teladoc Health (NYSE:TDOC), a leader in virtual care, has announced an inducement award for a new employee. Terre Layton, joining as Senior Vice President of Product for BetterHelp, received 50,000 restricted stock units of Teladoc Health's common stock on September 1, 2024. The vesting schedule is structured as follows:

• One-third of the shares vest on the first anniversary of the grant date
• The remaining two-thirds vest quarterly over the subsequent two years

This award, approved by the Compensation Committee of Teladoc's Board of Directors, was granted under the company's 2023 Employment Inducement Incentive Award Plan, in compliance with NYSE Rule 303A.08.

Harmonic Growth Partners, a leading expansion-stage investment firm, has announced the addition of Daniel Vernic as Principal to its investment team. This move strengthens Harmonic's unique investment model that combines experienced investors with world-class technology CEOs. Daniel, based in San Francisco, brings experience from Goldman Sachs and holds an M.B.A. from the University of Virginia Darden School of Business.

Harmonic's strategy integrates seasoned investors and accomplished technology CEOs, with the founding partners having backed industry leaders like Teladoc (NASDAQ: TDOC) and Peloton (NASDAQ: PTON). The firm's CEO Partners, including Dave Yarnold and Manolo Sanchez, have collectively driven over $15B in successful exits. Harmonic's portfolio includes market leaders such as ApplyBoard, Caribou, and Electric, offering a unique value proposition to expansion-stage management teams.

Teladoc Health reported its Q2 2024 financial results, showing mixed performance across segments. Revenue decreased 2% year-over-year to $642.4 million. The company recorded a net loss of $837.7 million, including a $790 million goodwill impairment charge related to BetterHelp. Adjusted EBITDA increased 24% to $89.5 million.

The Integrated Care segment grew 5% to $377.4 million in revenue with a 17% adjusted EBITDA margin. However, the BetterHelp segment declined 9% to $265 million with a 9.6% adjusted EBITDA margin. Teladoc withdrew its full-year 2024 guidance for consolidated operations and BetterHelp, as well as its three-year outlook, citing market conditions.